Workflow
泓博医药:公司的DiOrion-GPT大模型已向部分合作方开放试用,整体反馈积极

Core Insights - The company's DiOrion-GPT large model has been made available for trial to select partners, receiving positive feedback overall [2] - The company is currently optimizing multiple functions and upgrading the system, with updates expected to be announced in the coming months [2] CADD/AIDD Platform - By the end of 2024, the company’s CADD/AIDD technology platform is projected to have supported a total of 80 new drug projects [2] - The number of clients utilizing the company's CADD/AIDD services has reached 40 [2]